[1]中国医师协会放射肿瘤治疗医师分会,中华医学会放射肿瘤治疗学分会,中国抗癌协会肿瘤放射治疗专业委员会.中国食管癌放射治疗指南(2023年版)[J].国际肿瘤学杂志,2024,51(1):1-20.
Chinese Medical Association Radiation Oncology Physician Branch,Chinese Medical Association Radiation Oncology Therapy Branch,Chinese Anti Cancer Association Tumor Radiation Therapy Professional Committee.Chinese Guidelines for Radiation Therapy of Esophageal Cancer (2023 edition)[J].International Journal of Oncology,2024,51(1):1-20.
[2]TORRE LA,BRAY F,SIEGEL RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
[3]CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[4]刘杨,王昆仑,杨原源,等.食管癌患者生存分析及不同治疗方式影响因素的回顾性研究[J].中国临床医生杂志,2019,47(10):1208-1211.
LIU Y,WANG KL,YANG YY,et al.Survival analysis of patients with esophageal cancer and retrospective study of influencing factors of different treatment modalities[J].Chinese Journal for Clinicians,2019,47(10):1208-1211.
[5]张越栋.不同治疗方式对食管癌患者生存质量的影响[J].临床医药文献杂志,2016,27(3):5386-5388.
ZHANG YD.Effect of different treatment methods on quality of life of patients with esophageal cancer[J].Journal of Clinical Medical Literature,2016,27(3):5386-5388.
[6]彭进,朱卫国,骆红蕾.局限期小细胞食管癌不同治疗方式的回顾性研究及预后因素分析[J].临床肿瘤学杂志,2013,18(12):1112-1116.
PENG J,ZHU WG,LUO HL.Retrospective study on different treatment methods and prognostic factors of limited-stage small cell esophageal carcinoma[J].Journal of Clinical Oncology,2013,18(12):1112-1116.
[7]徐浩然,孙显松,王欣海,等.Halcyon医用电子直线加速器对142例肺癌患者常规分割治疗模式下靶区外放边界的分析[J].基础医学与临床,2020,40(12):1692-1694.
XU HR,SUN XS,WANG XH,et al.Analysis of target extension boundary in 142 patients with lung cancer by Halcyon medical electron linear accelerator[J].Basic Medical Sciences and Clinics,2020,40(12):1692-1694.
[8]李洪明,于浪,孙显松,等.MVCT引导下螺旋断层调强放射治疗摆位误差及靶区边界外放分析[J].中国医学装备,2017,14(7):55-58.
LI HM,YU L,SUN XS,et al.Analysis of positioning error and target boundary outplacement in MVCT-guided helical tomography intensive-modulated radiation therapy[J].China Medical Equipment,2017,14(7):55-58.
[9]普拉提·努尔别克,开丽曼·阿不都巴热,杨杰,等. 三维适形调强放疗治疗食管癌患者预后的影响因素[J].实用癌症杂志,2017,32(2):261-263.
PILATES NURBEK,KELIMAN ABDUPAGER,YANG J,et al.Prognostic factors of three dimensional conformal intensity modulated radiotherapy in patients with esophageal cancer[J].The Practical Journal of Cancer,2017,32(2):261-263.
[10]VAN HERK M.Errors and margins in radiotherapy [J].Semin Rasiat Oncol,2004,14(1):52-64.
[11]VAN HERK M,REMEIJER P,RASCH C,et al.The probability of correct target dosage:dose-population histograms for deriving treatment margins in radiotherapy[J].Int J Radiat Oncol Biol Phys,2000,47(4):1121-1135.
[12]LI C,TAN L,LIU X,et al.Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy:a propensity score-matched analysis[J].Thorac Cancer,2021,12:1831-1840.
[13]WANG X,GE X,ZHANG W,et al.S-1-based chemoradiotherapy followed by consolidation chemotherapy with S-1 in elderly patients with esophageal squamous cell carcinoma:A multicenter phase Ⅱ trial[J]. Front Oncol,2020,10:1499.
[14]NI W,YU S,XIAO Z,et al.Postoperative adjuvant therapy versus surgery alone for stage ⅡB-Ⅲ esophageal squamous cell carcinoma:A phase Ⅲ randomized controlled trial[J].Oncologist,2021,26:e2151-e2160.
[15]GAO LR,WANG X,HAN W,et al.A multicenter prospective phase Ⅲ clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer:3JECROG P-02 study protocol[J].BMC Cancer,2020,20:901.
[16]XING L,SIEBERS J,KEALL P.Computational challenges for image-guided radiation therapy:Framework and current research[J].Seminars in Radiation Oncology,2007,17(4):245-257.